Internal Medicine, Hematology & Oncology · Tulsa, OK
NPI
1730126111
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
11212 E 48th St
Tulsa, OK, 74146
Phone (918) 556-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
1,900 services
Medicare patients, 2024
355
Average age 75
Drug cost, 2024
$2.5M
1,300 prescriptions
Company payments, 2025
$677
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jihad Khattab was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 858 times for 323 patients. In total Jihad Khattab billed 1,900 services in 13 codes, and Medicare paid $77K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 858 | 323 | $11.46 | $9,834 |
| 99214 Office E&M - Established | Office | 634 | 213 | $66.35 | $42K |
| 99213 Office E&M - Established | Office | 227 | 163 | $43.41 | $9,853 |
| 99204 Office E&M - New | Office | 62 | 62 | $89.15 | $5,528 |
| 99223 Hospital E&M - Initial | Facility | 23 | 16 | $125.23 | $2,880 |
| 99215 Office E&M - Established | Office | 15 | 14 | $100.15 | $1,502 |
By year: 2022 $128K for 1,400 services; 2023 $86K for 1,122 services; 2024 $77K for 1,900 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jihad Khattab prescribed most often to Medicare patients was Letrozole, with 136 prescriptions and refills. In total Jihad Khattab wrote 1,300 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 136 | 264 | 27 | $2,804 |
| Acyclovir Generic | 69 | 95 | 13 | $1,129 |
| Gabapentin Generic | 60 | 64 | Under 11 | $993 |
| Eliquis Apixaban | 59 | 81 | 15 | $46K |
| Alendronate Sodium Generic | 54 | 68 | Under 11 | $436 |
| Enoxaparin Sodium Generic | 48 | 48 | Under 11 | $10K |
| Ondansetron Odt Ondansetron | 47 | 47 | 23 | $450 |
| Hydroxyurea Generic | 40 | 96 | Under 11 | $1,228 |
| Tamoxifen Citrate Generic | 37 | 80 | Under 11 | $830 |
| Prednisone Generic | 30 | 42 | Under 11 | $227 |
| Prochlorperazine Maleate Generic | 30 | 30 | 13 | $263 |
| Pilocarpine Hcl Generic | 29 | 43 | Under 11 | $1,935 |
| Abiraterone Acetate Generic | 29 | 32 | Under 11 | $116K |
| Pantoprazole Sodium Generic | 28 | 38 | Under 11 | $335 |
| Megestrol Acetate Generic | 28 | 30 | Under 11 | $2,242 |
Brand drugs: 220 claims; generic drugs: 1,080 claims; opioid claims: 67.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jihad Khattab $677 ($677 in general payments such as food, travel and fees) from 12 companies. The largest payer was Celgene Corporation with $176.
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation BMY | 15 | $176 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $165 |
| Abbvie Inc. ABBV | 5 | $97.53 |
| GlaxoSmithKline, LLC. GSK | 2 | $42.73 |
| BeOne Medicines USA, Inc. ONC | 2 | $38.99 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $36.53 |
| Daiichi Sankyo Inc. 4568.T | 1 | $22.66 |
| Recordati_rare_diseases_inc. | 1 | $22.63 |
| Pfizer Inc. PFE | 1 | $21.6 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $18.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.